Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 1 | |||||
| (NASDAQ: AXSM) | Delayed: 246.34 +0.70 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.64 | 52 Week High | $15.74 | |||
| Open | $246.18 | 52 Week Low | $5.37 | |||
| Day High | $256.00 | P/E | N/A | |||
| Day Low | $245.11 | EPS | $0.00 | |||
| Volume | 741,310 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.77 -0.16 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $4.66 | |||
| Open | $2.90 | 52 Week Low | $2.01 | |||
| Day High | $2.95 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $0.00 | |||
| Volume | 300,818 | |||||

